Hello Avatar! Welcome back for another week of biotech analysis. This week we will provide insight into how pre-product biotech companies are valued for M&A. In past posts we have gone through valuation methods for biotech venture deals - reminder: it is purely based on market comps. For M&A it is the exact same situation. Everything they teach you in…
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.